Nanotherapeutics for neurosurgically-applied drug delivery
Sign Up to like & getrecommendations! Published in 2019 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noz167.067
Abstract: Despite multimodal treatment, the median survival of Glioblastoma multiforme (GBM) remains less than 15 months, in considerable part due to diffusely infiltrative disease. Better treatment methods are necessary to eradicate residual tumour burden remaining beyond… read more here.
Keywords: neurosurgically applied; delivery; drug; pro drugs ... See more keywords